IL33 and neoplasm: Thus, we next examined mast cells in IL-33 deficient gp130F/F mice, focusing on the two major subsets, connective tissue mast cells (CTMC) and mucosal mast cells (MMC), which differ in their histochemical and molecular characteristics, cytokine profiles and crucially, role in tumour progression [40].